IDT earns ISO 9001:2008 certification at its European oligonucleotide production hq
Worldwide certification of quality systems at all manufacturing operations completed and GMP service for oligo drug development added
All three IDT oligonucleotide facilities (Coralville, Iowa; San Diego, California; and Leuven, Belgium) now offer ISO 9001:2008 certification, with the Coralville manufacturing headquarters also providing ISO 13485:2003 certification for the manufacture of diagnostic oligonucleotides.
In addition, IDT’s Leuven facility will begin offering quality control and batch record services that are consistent with Good Manufacturing Practice (GMP) requirements associated with drug development activities.
'We are continually striving to provide the highest quality oligos as fast as possible to our customers, and this certification completes the company’s mission of having ISO 9001:2008 as a quality systems baseline for all of IDT’s manufacturing operations worldwide,' noted Rick McConahay, General Manager of IDT’s European Operations.
'It is also an important milestone for our European operation, which has experienced very rapid growth since its launch in the summer of 2008. It is a significant achievement to have grown from a simple start-up to making thousands of oligos per day, and in the process also implement and certify an ISO 9001:2008 compliant quality system.'
Certification followed an audit by BSI Management Systems, a prominent quality management systems registrar – requiring on-site assessments, examinations of IDT's documented procedures and an audit of overall operations. System quality and standards will subsequently be monitored by BSI Management Systems through periodic surveillance audits of IDT's processes.
The certification also marks IDT’s formal launch of a GMP analytical service for its oligo customers, who require GMP quality control and batch record services for their drug development activities. IDT has enhanced its analytical, batch recording and endotoxin testing capabilities, integrating these into the appropriate quality system infrastructure to deliver GMP solutions to its drug development customers.
With this additional service, IDT now offers oligonucleotides for all applications (research, diagnostic and therapeutic), at scales ranging from 25 nanomoles to 10 grams.
You may also like
Trending Articles
You may also like
Manufacturing
Domino demonstrates an integrated approach to next-generation coding at Interpack 2026
At Interpack 2026, Domino Printing Sciences (Domino) will focus on the key challenges manufacturers face as variable data printing enters a new era shaped by 2D codes, intelligent automation, sustainability, and growing traceability demands. Domino specialists will be available throughout the show to highlight integrated solutions designed to work together on the factory floor – developed in collaboration with key industry partners to help to reduce complexity, risk, and operational friction for manufacturers
Manufacturing
Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target
BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target
Manufacturing
Former Catalent Chair and CEO George Fotiades joins eXmoor Pharma board as Chair
Angela Osborne steps back from operational duties and continues as Founder and Board Director, providing strategic continuity as eXmoor builds the leadership depth to support its expanding integrated CDMO model